MASLEIDY FORNOS ARTILES: Open Payments
NPI 1851067730 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,461 in 98 payments from 30 companies in 2025. Trend: 2023 $1,061 · 2024 $1,942 · 2025 $2,461
Food & beverage: $2,461
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $246 |
| Novo Nordisk Inc | 9 | $208 |
| Novartis Pharmaceuticals Corporation | 7 | $195 |
| Tandem Diabetes Care, Inc. | 7 | $177 |
| Lilly USA, LLC | 10 | $175 |
| AstraZeneca Pharmaceuticals LP | 1 | $161 |
| CSL Behring | 6 | $152 |
| Amgen Inc. | 6 | $114 |
| Insulet Corporation | 3 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
Products named: CUVITRU, t:slim X2 Insulin Pump with Control-IQ, TEZSPIRE, Rybelsus, MOUNJARO, Omnipod, JARDIANCE, EVENITY.
Industry payments across FL — which companies pay providers there.
